pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Clinical Research 104

XTalks

MARCH 5, 2021

The acquisition will see ICON plc, global provider of development and commercialization services to the pharmaceutical, biotechnology and medical device industries, expand its portfolio to leverage PRA’s mobile and connected health platforms, along with its data and information solutions. Accelerating Development.

Development 98

Development Trials Clinical Development Medicine 98

VirTrial

DECEMBER 8, 2023

If you missed Signant’s November 15 webinar about utilizing EDC for modern clinical trials, there is still time. And if so, how can EDC systems address the evolving requirements of modern clinical trials? And if so, how can EDC systems address the evolving requirements of modern clinical trials?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Production 52

WCG Clinical

SEPTEMBER 11, 2023

Listen and Subscribe: Apple PodCASTs Spotify Google PoDCASTS About this episode: In episode three of WCG Talks Trials , two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report , which provides a 360-degree view on motivators and deterrents to clinical trial participation.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Clinical Research 59

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

XTalks

MAY 20, 2021

Today is Clinical Trials Day 2021 — a day for recognizing the importance of clinical research in protecting and improving global health. Amid the alarmist headlines posted by other media outlets, Xtalks has remained balanced in its reporting of COVID-19 clinical trial results and safety data.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Vaccination 105

The Pharma Data

OCTOBER 29, 2020

Biotechs get scalable early to late phase clinical offering from Cromos Pharma and Avance Clinical collaboration in Australia and Europe. on clinical trial costs, throughout all study phases, across both regions. “We Cromos Pharma can access hundreds of millions of patients via more than 2,500 sites in Central/Eastern Europe.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Clinical Research 40

VirTrial

OCTOBER 25, 2023

In recent years, Signant has been a part of more than 95 vaccine studies involving 140,000+ patients in more than 30 countries. Let’s take a brief look at the history of vaccines, how the COVID-19 pandemic changed the landscape, and where the future of vaccine development is headed.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

The Pharma Data

OCTOBER 19, 2020

The Alliance is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer. Curran, Jr. ,

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

pharmaphorum

JANUARY 19, 2021

A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. CEO Jeremy Edwards looks at how decentralised trial models can solve some of the challenges for clinical trial recruitment in rare disease.

Trials 107

Trials Research Clinical Trials Clinical Trials 107

The Pharma Data

SEPTEMBER 11, 2020

This week’s round up dives into developments from companies based in Australia and the US. Remdesivir is an antiviral drug, currently being developed by Gilead to treat Covid-19 and has emergency use authorization from the US Food and Drug Administration for the treatment of Covid-19. Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Drug Discovery World

OCTOBER 16, 2023

A company within this ecosystem is STORM Therapeutics, a clinical stage biotechnology company creating novel small molecule therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. Here, DDW’s Megan Thomas highlights the research taking place and where this is happening.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

XTalks

MAY 19, 2023

Clinical trials play a vital role in advancing patient treatment and medical care. This article delves into ten trends and statistics in the world of clinical trials for 2023. Increasing Number of Registered Clinical Trials As of May 17, 2023, there are 452,604 registered clinical trials globally on ClinicalTrials.gov.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Cloudbyz

MAY 25, 2020

Even the teenagers of this contemporary age were discussing and searching about the clinical trials over the internet. Many of the world’s powerful bureaucracies are closely monitoring the curiosity spinning around clinical trials. Site Management. What’s the basis for such significance? Investigator Database Management/portal.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Development Trials 52

Worldwide Clinical Trials

NOVEMBER 21, 2023

As a provider of end-to-end clinical development solutions, we plan to leverage our expertise to refine drug-disease matches identified by Every Cure’s use of AI and data analysis. There are so many patients suffering from diseases that have no treatments.

Clinical Trials 171

Clinical Trials Clinical Trials Clinical Development Drugs 171

XTalks

JANUARY 5, 2021

The pandemic itself will also continue to spur innovations and changes such as greater shifts towards decentralized clinical trials and patient-centric approaches. In addition to vaccines, there are handfuls of drugs currently being evaluated in clinical trials for the treatment of COVID-19.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

DECEMBER 4, 2020

Since CKD is a broad diagnosis that can have a variety of underlying causes, a beneficial focus of current research strategies has been to identify biomarkers and develop diagnostics that can help stratify patients into clinically relevant categories and help guide their management. What is Chronic Kidney Disease?

Trials 52

Trials Clinical Trials Clinical Trials Antibody 52

The Pharma Data

JULY 8, 2021

ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia. Food and Drug Administration (FDA) has approved an updated label for ADUHELM (aducanumab-avwa) injection 100 mg/mL solution. What is the most important information a patient should know about ADUHELM?

Clinical Trials 52

Clinical Trials Clinical Trials FDA Approval Trials 52

Drug Discovery World

APRIL 10, 2024

Recent advancements in obesity treatments, exemplified by the approvals of semaglutide and tirzepatide, have spotlighted the field for healthcare providers and developers.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Hormones 52

The Pharma Data

JULY 21, 2021

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. Valneva and Pfizer entered into a collaboration agreement in April 2020 to co-develop VLA15 2. at Month 7).

Vaccination 52

Vaccination Vaccine Trials Bacteria 52

Pharma Marketing Network

JUNE 8, 2020

I’m your host Don Langsdorf and I am here today with Bob Baurys and Mark Stinson from 83Bar and also the authors of patient activation. I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked.

Doctors 40

Doctors Doctor Clinical Trials Clinical Trials 40

The Pharma Data

NOVEMBER 10, 2020

Phase1b/2 clinical study to be conducted in the United States and several European countries. This clinical study will evaluate the safety, tolerability, and clinical activity of escalating doses of orally administered capsules of Foralumab. Crohn’s Disease Therapeutics Market Size $4.7 Billion by 2025.

Life Science 40

Life Science Clinical Trials Clinical Trials Trials 40

The Pharma Data

DECEMBER 11, 2020

“Pfizer’s purpose is breakthroughs that change patients’ lives, and in our 171-year history there has never been a more urgent need for a breakthrough than today with hundreds of thousands of people continuing to suffer from COVID-19,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. . immediately.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

WCG Clinical

JULY 17, 2023

Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report , gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

The Pharma Data

DECEMBER 1, 2020

The data submitted to regulatory agencies around the world are the result of a scientifically rigorous and highly ethical research and development program.”. The data submitted to regulatory agencies around the world are the result of a scientifically rigorous and highly ethical research and development program.”. 2, 2020 07:05 UTC.

Vaccination 40

Vaccination Vaccine Manufacturing Clinical Trials 40

The Pharma Data

DECEMBER 27, 2020

NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided a year-end review and an outline of its plans for 2021. .–( BUSINESS WIRE )– Lineage Cell Therapeutics, Inc.

Manufacturing 52

Manufacturing Production Development Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines. FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

— Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines. FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

pharmaphorum

AUGUST 24, 2022

Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. Why, not how. Community-led.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Development 95

Crucial Data Soutions

JUNE 8, 2020

Crucial Data Solutions, Inc. CDS), a provider of innovative software to advance clinical research, announced today a number of enhancements to their data collection and study management platform, TrialKit. The TrialKit platform received updates to its eConsent and ePRO modules to advance remote data collection and management.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Development 52

Pharma Marketing Network

APRIL 30, 2021

Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

pharmaphorum

MAY 27, 2021

As an industry, we must take the principles that led to the successful development of vaccines in record time and apply them to other serious medical conditions that may lack the urgency of a pandemic but still affect millions of lives every year. Increase in data sources and providers. Implementing AI/machine learning models.

Clinical Trials 118

Clinical Trials Clinical Trials Trials Life Science 118

Drug Discovery World

JANUARY 12, 2023

Protas was early off the mark when this non-profit organisation was launched on 24 January to design and deliver large, inclusive, randomised clinical trials, working in collaboration with industry partners, medical charities, patient groups, academic researchers, and frontline clinical teams.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

The Pharma Data

MAY 16, 2022

Food and Drug Administration (FDA) has lifted the clinical hold placed on the company’s Investigational New Drug Application (IND) to evaluate injectable lenacapavir for HIV treatment and HIV pre-exposure prophylaxis (PrEP). Gilead Sciences, Inc. Nasdaq: GILD) today announced the U.S. There is no cure for HIV or AIDS. About Lenacapavir.

Medicine 52

Medicine Drugs Development Trials 52

The Pharma Data

NOVEMBER 8, 2020

Ilumetri ® sales grew +125% year-on-year and Seysara ® showed Net Sales performance improvement quarter-on-quarter following clinically relevant FDA label improvement. In 2017 we bet on refocusing our strategy on medical dermatology to best address patients’ unmet needs. BARCELONA, Spain , Nov. MM (-3.7%; +4.3% .

Dermatology 52

Dermatology Sales Marketing Production 52

The Pharma Data

APRIL 7, 2023

Merck and Eisai are informing study investigators of the decision and advising them to reach out to patients in the study regarding treatment. We remain fully committed to building on existing treatments as part of our efforts to help as many appropriate patients with cancer as we can,” said Dr.

Trials 40

Trials Clinical Trials Clinical Trials Development 40

The Pharma Data

MARCH 26, 2021

Results of the interim analysis, based on data from 583 patients enrolled in the trial, demonstrated an 85% (p=0.002) reduction in hospitalisation or death in those receiving VIR-7831 compared to placebo, the primary endpoint of the trial. The interim analysis included 291 patients in the treatment arm and 292 patients in the placebo arm.

Antibody 52

Antibody Trials Vaccination Vaccine 52